Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,103 | 188,785 | 197,370 | 228,684 | 251,253 |
| Other current assets | 0 | 0 | 0 | 128 | 0 |
| TOTAL | $159,602 | $197,170 | $207,302 | $239,629 | $257,879 |
| Non-Current Assets | |||||
| PPE Net | 50,610 | 40,553 | 33,867 | 2,497 | 287 |
| Other Non-Current Assets | 3,744 | 3,319 | 691 | 703 | 715 |
| TOTAL | $54,354 | $43,872 | $34,558 | $3,200 | $1,002 |
| Total Assets | $213,956 | $241,042 | $241,860 | $242,829 | $258,881 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,763 | 22,051 | 6,355 | 4,083 | 1,994 |
| Accrued Expenses | 29,983 | 21,163 | 22,036 | 14,875 | 5,135 |
| TOTAL | $51,746 | $43,214 | $28,391 | $18,958 | $7,129 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,192 | 27,812 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 29,635 | 29,622 | 26,974 | 999 | 450 |
| TOTAL | $66,827 | $57,434 | $26,974 | $999 | $450 |
| Total Liabilities | $118,573 | $100,648 | $55,365 | $19,957 | $7,579 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,474 | 38,474 | 38,391 | 37,917 | 37,761 |
| Retained earnings | -235,649 | -185,263 | -134,076 | -93,150 | -61,126 |
| TOTAL | $95,383 | $140,394 | $186,495 | $222,872 | $251,302 |
| Total Liabilities And Equity | $213,956 | $241,042 | $241,860 | $242,829 | $258,881 |